Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Nordic Life Science Insight's Logo
2017
April
May
June
July
August
September
October
November
December
Select month
20182019

2017

-

June

Date
Title
Category
Company
June 7, 2017
FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia
Pharma
Novo Nordisk Pharmatech A/S
June 8, 2017
Spago Nanomedical and Charles River Laboratories announce agreement for preclinical studies of SpagoPix
Life Science
Spago Nanomedical
June 9, 2017
Spago Nanomedical appoints product candidate in the SpagoPix-project
Life Science
Spago Nanomedical
June 12, 2017
Xultophy® 100/3.6 demonstrated similar A1C reductions with significantly lower rates of hypoglycemia and a decrease in weight vs basal-bolus therapy
Pharma
Novo Nordisk Pharmatech A/S
June 16, 2017
SpagoPix product patent approved in Japan
Life Science
Spago Nanomedical
June 19, 2017
SpagoPix promising results in toxicological pilot studies
Life Science
Spago Nanomedical
June 19, 2017
FDA posts briefing materials prior to Advisory Committee meeting for Victoza® label update
Pharma
Novo Nordisk Pharmatech A/S
June 20, 2017
Spago Nanomedical and Charles River Laboratories announce agreement for preclinical studies of SpagoPix
Life Science
Spago Nanomedical
June 21, 2017
Novo Nordisk receives positive 17-2 vote from FDA Advisory Committee that Victoza® provides substantial evidence of cardiovascular risk reduction in patients with type 2 diabetes
Pharma
Spago Nanomedical
June 21, 2017
InDex Pharmaceuticals enrolls first patient in the phase IIb study CONDUCT with cobitolimod
Pharma
InDex Pharmaceuticals
June 23, 2017
Opening a new door to cell and gene therapy accessible to all
Life Science
Medicon Village AB
June 26, 2017
20 Years anniversary medicon valley alliance
Life Science
Medicon Valley Alliance
June 29, 2017
International Collaboration in Cancer Innovation
Life Science
Oslo Cancer Cluster

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019